BPC-157 and TB-500 stacks are popular for comprehensive healing support
Stacking two GLP-1 class compounds (e.g., semaglutide + tirzepatide) is not supported by any clinical trial, is likely to produce additive GI side effects, and has no mechanistic rationale the receptors overlap too much
GHK (glycyl-L-histidyl-Llysine), a naturally occurring peptide, has demonstrated the potential in modulating fibrotic pathways by reversing cellular senescence and inducing apoptosis in myofibroblasts
This is why combining cagrilintide with semaglutide produces synergistic effects
BPC 157 application largely counteracted changes at the microscopic level, including the formation of vacuoles and the loss of axons in the white matter, the formation of edema and the loss of motoneurons in the gray matter, and a decreased number of large myelinated axons in the rat caudal nerve from day 7